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Effects of vigabatrin, carbamazepine or its combination on the pituitary-
gonadal axis in male Wistar rats




Objectives: Epilepsy is the most common non-infectious neurologic disease in developing African 
countries following stroke and Alzheimer's disease. Most conventional antiepileptic drugs, due to their 
centrally acting potentials have been implicated in the deregulation of reproductive hormones. This study 
assessed the effect of the single and combined administration of vigabatrin (VIG) and carbamazepine 
(CBZ) on the pituitary-gonadal axis of male Wistar rats.
Methods: Fifty male Wistar rats were randomly divided into 5 groups (n=10). The animals were 
administered with distilled water (0.1 ml/kg/day), VIG (200 mg/kg/day), CBZ (200 mg/kg/day), VIG-
CBZ combination (100 mg/kg/day each) and VIG-CBZ combination (200 mg/kg/day each) for 8 weeks. 
Twenty-four hours after the last dose, 5 rats from each group were sacrificed, while the remaining 5 
eventually sacrificed after another 8 week of drug withdrawal. The level of luteinizing hormone, follicle 
stimulating hormone and testosterone were determined from the serum. The weight of the reproductive 
organs and sperm indices were assayed, while the testicular tissue were examined for signs of histological 
alteration.
Results: The results showed significant decrease in the levels of luteinizing hormone, follicle stimulating 
hormone, testosterone and sperm physiological indices. Morphological alteration was noticed in the testes 
of all the treated rats. However, there was restoration of these parameters sequelae to 8 weeks cessation of 
treatment.
Conclusion: Single and combined administration of VIG and CBZ resulted into pituitary-gonadal axis 
hormonal deregulation and alterations in the sperm profile which were however reversible upon 
cessation of treatment.
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Effets de la vigabatrine, de la carbamazépine ou de sa combinaison sur 
l'axe hypophyso-gonadique chez des rats Wistar mâles
1 2 1,3 1,4 5
6
Resume
Objectif: L'épilepsie est la maladie neurologique non infectieuse la plus fréquente dans les pays africains 
en développement après un AVC et la maladie d'Alzheimer. La plupart des médicaments antiépileptiques 
conventionnels, en raison de leurs potentiels d'action centraux, ont été impliqués dans la dérégulation des 
hormones de la reproduction. Cette étude a évalué l'effet de l'administration unique et combinée de 
vigabatrine (VIG) et de carbamazépine (CBZ) sur l'axe hypophyso-gonadique de rats mâles Wistar.
Méthodes: Cinquante rats Wistar mâles ont été divisés au hasard en 5 groupes (n = 10). Les animaux ont 
été administrés avec de l'eau distillée (0,1 ml / kg / jour), VIG (200 mg / kg / jour), CBZ (200 mg / kg / jour), 
combinaison VIG-CBZ (100 mg / kg / jour chacun) et Combinaison VIG-CBZ (200 mg / kg / jour chacun) 
pendant 8 semaines. Vingt-quatre heures après la dose perdue, 5 rats de chaque groupe ont été sacrifiés, 
tandis que les 5 restants ont finalement été sacrifiés après 8 semaines de retrait de médicament. Le niveau 
d'hormone lutéinisante, la testostérone, hormone folliculo-stimulante et le glutathion réduit ont été 
déterminés à partir du sérum, le poids des organes reproducteurs et les indices de sperme ont été testés, 
tandis que le tissu testiculaire a été examiné pour toute altération histologique.
Résultats: Les résultats ont montré une diminution significative des taux d'hormone lutéinisante, 
d'hormone folliculo-stimulante, de testostérone, de paramètres du sperme et de glutathion. Une altération 
histologique a été observée dans les testicules de tous les rats traités. Cependant, il y avait une restauration 
de ces paramètres séquelles à 8 semaines d'arrêt du traitement.
Conclusion: L'administration unique et combinée de VIG et de CBZ a entraîné des modifications 
physiopathologiques du profil hormonal de l'axe hypophyso-gonadique et une diminution du marqueur 
antioxydant qui était cependant réversible à l'arrêt de l'administration du médicament.
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INTRODUCTION
Epilepsy is the most common non-
infectious neurologic disease following stroke 
and Alzheimer's disease (1). It occurs in about 1% 
of people worldwide (65 million)(2) with nearly 
80% of cases occurring in developing countries 
(3) including Nigeria (1) and it remains a major 
medical and social problem (2). Epilepsy cannot 
be cured, but seizures are controllable with 
medication in about 70% of cases (4). About 5–10 
% of all people will have an unprovoked seizure 
(5) by the age of 80, and the chance of 
experiencing a second seizure is between 40 and 
50 % (6). The highest incidence of new cases 
occurs among children less than 5 years (50-100 
cases/100,000) and adults greater than 65 years of 
age (70-150 cases/100,000) (7). These seizures 
are episodes that can vary from brief and nearly 
undetectable to long periods of vigorous shaking 
(8). However, a lot of antiepileptic drugs are used 
in the treatment and management of seizures. 
These drugs include pregabalin, zonisamide, 
CBZ, VIG, phenytoin, sodium valproate, 
gabapentin (9) to mention but a few. 
Monotherapy treatment of epilepsy is very 
common and a good choice especially for newly 
diagnosed epilepsy. However a combination of 
two antiepileptic drugs is usually considered 
when there is failure or lack of efficacy of the 
monotherapy regimens (10).
Today, the roles of epilepsy and 
antiepileptic medication in contributing to 
reproductive endocrine disorders in people with 
epilepsy are still widely debated. Epilepsy itself 
may disturb the regulation of secretion of 
reproductive hormones (11) while on the other 
hand, antiepileptic drugs (AEDs) have also been 
shown to induce reproductive endocrine 
disorders (12).  Mono-therapeutic treatment of 
epilepsy using a conventional antiepileptic drug 
carbamazepine has been reported to have 
prominent adverse effects especially on testicular 
functions (13). Vigabatrin is a newer antiepileptic 
which is used as an adjunct therapy in the 
treatment of epilepsy (14). However, reports on 
the combination of these drugs on reproductive 
functions have not been reported and need to be 
investigated, hence this study.
MATERIALS AND METHODS
Fifty adult male Wistar strain rats 
weighing 120 g - 150 g were used for this study. 
They were obtained from the Animal House of 
the College of Health Sciences, Obafemi 
Awolowo University, Ile-Ife and were housed in 
separate cages. The animals were kept under 
normal environmental conditions and had free 
access to standard rodent pellet diet (Caps Feed 
Plc Osogbo, Nigeria) and water ad libitum. They 
were allowed to acclimatize in the laboratory for 
2 weeks before the commencement of the study. 
The experimental procedures adopted in this 
study were in strict compliance with 
Experimental Animal Care and Use of 
Laboratory Animals in Biomedical Research, 
College of Health Sciences, Obafemi Awolowo 
University, Ile-Ife. The animals were randomly 
divided into 5 groups, each consisted of 10 
animals except the control group of 5 rats.
Vigabatrin (VIG) and carbamazepine 
(CBZ) obtained from Novartis, Switzerland were 
used for this study. Vigabatrin is water-soluble; 
therefore, it was dissolved in distilled water. Five 
hundred milligrams (500mg) of VIG was 
dissolved in 5ml of distilled water. CBZ is not 
water-soluble, therefore, tween 80 was used to 
dissolve carbamazepine. Two hundred 
milligrams (200mg) of carbamazepine was 
dissolved in 1ml of tween 80 and calculated 
amounts were administered to the rats orally.
Group 1 which was the control group 
received distilled water (0.1ml) orally for 8 
weeks; Group 2 received 200mg/kg/day of VIG 
 
orally for 8 weeks (15). Group 3 received 
200mg/kg/day of carbamazepine orally for 8 
 weeks (16). Group 4 was given 100mg/kg/day of 
VIG in combination with 100mg/kg/day of 
carbamazepine orally for 8 weeks. Group 5 
received VIG (200mg/kg/day) in combination 
with CBZ (200mg/kg/day) orally for 8 weeks. 
Twenty- four hours after the last drug 
administration, 5 rats from groups 1-5 (were 
picked at random) were sacrificed through 
cervical dislocation. Blood samples were 
collected via cardiac puncture and were 
centrifuged for 15 minutes at 4000rpm using cold 
centrifuge (4°C) to obtain serum which was used 
for hormonal assays. Sperm characteristics 
(sperm count,  viabil i ty,  motil i ty and 
morphology) were also evaluated using 
conventional methodology. The remaining rats in 
Groups 1-5 were allowed to recover from the 
effects of the drug(s) for a period of 8 weeks and 
sacrificed 24 hours after the lapse of 8 weeks of 
recovery period, afterwards the assessment of the 
aforementioned parameters were also carried out.
The effects of the administered drugs on 
ththe body weight of the rats was determined at 24  
hour after the last dose, just before the sacrifice 
with sensitive digital weighing balance (Camry, 
China). Rats were dissected and the reproductive 
tract was taken out trimmed free of fat and the 
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following organs: epididymis and testes were 
removed and weighed separately on a sensitive 
electronic weighing balance. The testes were 
fixed in 10% formol saline for further histological 
studies.
Sperm counts were assessed immediately 
the rats were sacrificed using a counting chamber 
as earlier described by Raji et al. (17),  where the 
total number of sperm in the ejaculate= The 
concentration of sperm per ml X the total number 
of ml of raw semen. The results were expressed as 
million/ml suspension.
Epididymal sperm motility was assessed 
immediately the rats were sacrificed. Sperm 
progressive motility was determined according to 
the procedure reported by Otoom et al. (18). The 
number of motile spermatozoa were calculated 
per unit area and expressed as percentage 
motility.
Viability study was done as described by Maree et 
al. (19). Morphological aberrations of abnormal 
spermatozoa were determined from a total count 
of 400 spermatozoa in smears obtained with 
Eosin and Nigrosin stain.
Serum testosterone concentration was 
de termined us ing  the  enzyme- l inked 
immunosorbent assay (ELISA) via the use of 
ELISA kit (MonobindInc, Lake Forest, CA 
92630, USA) as described by the manufacturer's 
instruction. 
Testicular histology was carried out 
according to Raji, et al. (20). The testes were 
fixed in 10% formol saline immediately after 
weighing. The preserved testes were then passed 
through the routine laboratory histological 
procedures and slides were stained with 
haematoxylin and eosin. Sections were viewed 
under the microscope with photomicrograph 
taken with a Leica DM750 camera microscope.
Data collected were analysed using 
descriptive and inferential statistics. The control 
and test groups were compared using t-test, 
ANOVA and Student-Newman-Keuls post hoc 
analysis where appropriate using GraphPad 
Prism 5.03 (GraphPad Software Inc., CA, USA) 
as the statistical analysis package. The results 
were presented as mean ± SEM in graphs and 
tables and the level of significance was taken as 
p-value < 0.05. 
RESULTS
In  th i s  s tudy,  VIG (200mg/kg)  
significantly (p<0.05) decreased the body weight 
of the treated rats compared to the control group. 
Although these animals were unable to fully 
recover after 56 days of drug withdrawal but there 
was a significant (p<0.05) increase in the 
percentage weight gain (Table 1)
Eight weeks of VIG (200mg/kg) treatment 
significantly (p<0.05) increased the epididymal 
weight while CBZ (200mg/kg) significantly 
(p<0.05) decreased it (Figure 1). There was no 
significant difference (p<0.05) in the weight of 
epididymis after VIG (100mg/kg) + CBZ 
(100mg/kg) combination treatment compared to 
the control while VIG (200mg/kg) + CBZ 
(200mg/kg) significantly (p<0.05) increased 
epididymal weight. 
In Figure 2, the relative testicular weight  
of VIG (200mg/kg), VIG (100mg/kg) + CBZ 
(100mg/kg) and VIG (200mg/kg) + CBZ 
(200mg/kg)  combinat ion t reated ra ts  
significantly (P<0.05) increased  but decreased in 
CBZ (200mg/kg) compared to control. 
In the study, VIG (200mg/kg), CBZ 
(200mg/kg),  VIG (100mg/kg) + CBZ 
(100mg/kg) and the VIG (200mg/kg) + CBZ 
( 2 0 0 m g / k g )  c o m b i n a t i o n  t r e a t m e n t s  
significantly (p< 0.05) decreased the testosterone 
in male Wistar rats and this effects were not 
reverted despite 8 weeks of drug withdrawal 
(Figure 3).
VIG (200mg/kg), CBZ (200mg/kg), VIG 
(100mg/kg) + CBZ (100mg/kg) or VIG 
(200mg/kg) + CBZ (200mg/kg) combination 
treatments had no significant (p<0.05) difference 
on the serum luteinizing hormone concentration. 
However, withdrawal of the treatments brought 
about a significant (p<0.05) decrease in the 
concentration of luteinizing hormone compared 
with their control counterpart (Figure 4).
VIG (200mg/kg) significantly (p<0.05) 
decreased the FSH concentration while CBZ 
(200mg/kg),  VIG (100mg/kg) + CBZ 
(100mg/kg) and VIG (200mg/kg) + CBZ 
(200mg/kg) significantly (p<0.05) increased the 
serum FSH concentration. However, despite the 
drug withdrawal, there was still a significant 
(p<0.05) increase (p<0.05) in the serum FSH 
concentration of VIG (200mg/kg) and CBZ 
(200mg/kg) treated groups compared to their 
control (Figure 6).
VIG (200mg/kg), CBZ (200mg/kg) VIG 
(100mg/kg) + CBZ (100mg/kg) and VIG 
(200mg/kg) + CBZ (200mg/kg) significantly 
(p<0.05) decreased the sperm count, motility, 
viability and normal morphology compared to 
the control. (Table 2).
F i g u r e  7 a  a n d  b  s h o w e d  t h e  
histomorphology of the testes of rats treated with 
VIG (200mg/kg), CBZ (200mg/kg), VIG 
(100mg/kg) + CBZ (100mg/kg) and VIG 
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(200mg/kg) + CBZ (200mg/kg) combination 
treated rats revealed signs of vacuolation in the 
interstitial cell (IC) compared to the control 
except the VIG (100mg/kg) + CBZ (100mg/kg) 
treated. Degenerating features earlier noticed 
were reverted consequent upon drug withdrawal 
except the vacuolated interstitial cells in the VIG 
(100mg/kg) + CBZ (100mg/kg) combination 
treated rats' testicles.
DISCUSSION
The study assessed the effects of 8 weeks 
treatment and another 8 weeks of drug 
withdrawal of the conventional antiepileptic drug 
CBZ, newer antiepileptic drug VIG or the 
combination of the two on the hypothalamic-
pituitary-testicular axis. Bearing in mind that 
these two antiepileptics are centrally acting 
drugs, this therefore suggests that these drugs 
either alone or in combination might have 
interacted with the ventrolateral hypothalamus 
(VLH).lesion to this part of hypothalamus 
induces anorexic condition that might have 
resulted in animals failure to feeding, wasting of 
muscle and ultimately loss in body weight. This 
finding is in line with the previous reports that 
vigabatrin administration is associated with 
weight reduction through its anorexic (21). CBZ 
chronic treatment has also been reported in the 
earlier study to inhibit weight gain (21). The 
findings of this report imply that administration 
of antiepileptic drugs (AEDs) used in this study 
have the ability to inhibit hypothalamic neurons 
associated with the regulation of food 
consumption and energy expenditure thereby 
leading to loss of appetite. Consequently, there 
was a decrease in body weight gain throughout 
the course of the study since body weight gain or 
loss depends on the balance between food 
consumption/calorie intake and energy 
expenditure. The brain integrates information 
from many afferent inputs and circulating factors 
to regulate food intake and energy expenditure. 
The significant decrease in body weight of rats 
during the periods of drug administration and 
recovery can also be attributed to an alteration in 
caloric balance and lesions of the ventromedial 
nuclei of the hypothalamus (Satiety centre) and 
the ventrolateral hypothalamic nuclei (Feeding 
centre) producing a syndrome of aphagia and 
weight loss in the experimental animals as an 
indication of the effects of the drugs on these 
centers (22). This is in contrary to previous 
studies which reported that administration of 
AEDs increased the level of Cortisol, leptin and 
neuropeptide Y'' (21, 22, 23).
This suggests that VIG treatment and 
combination therapy of CBZ/ VIG (200mg/kg) 
are associated with significant increase in relative 
testicular weights in rats. This effect was 
observed in the relative epididymal weights of 
these rats. This is contrary to the findings of 
Daoud et al. (15) who reported significant 
decrease in relative testicular and epididymal 
weights in rats treated with VIG. The effects of 
antiepileptic drugs on the reproductive function 
could be attributed to their central effects on 
hypothalamic-pituitary-gonad axis. Most of 
antiepileptic drugs act as GABA-agonists. The 
GABA –ergic system is the predominant 
inhibitory system in the mammalian central 
nervous system. GABA nerve fibers showed high 
density in the hypothalamus, posterior and 
intermediate lobes of  pi tui tary (23).  
Administration of carbamazepine (4 to 52 weeks 
at dosage levels of 50-400 mg/kg/day) has been 
reported to be associated with testicular atrophy 
(11). The restoration of these parameters towards 
control values after the recovery period suggests 
that vigabatrin and carbamazepine treatment 
have reversible deleterious effects (11).
The fact that sperm count gives the 
cumulative result of all stages in sperm 
production makes it one of the most reliable 
sensitive tests for spermatogenesis (24). It is one 
of the most sensitive tests for spermatogenesis 
and highly correlated with fertility (25). In rats, 
spermatogenesis takes place within a period of 50 
and 60 days (26). This study suggests that 
spermatogonia cells were vulnerable to the toxic 
effects of VIG, CBZ and their combination. 
Chemica l s  which  in te r fe re  wi th  the  
spermatogonial (earliest) phase of cell 
multiplication may have a disproportionately 
greater effect on sperm output than those that 
exert their effects at the spermatid phase since the 
spermatogonial phase is when almost all cell 
multiplication occurs (27). This was, however, 
buttressed with the fact that the study recorded a 
significant decrease in the total number of 
abnormal sperm cells (in the experimental 
groups) at the end of the study when compared 
with the control group.
The decline in sperm motility could have 
been due to an assault to the histoarchitecture of 
the seminal vesicles with a corresponding 
functional decline in fructose-producing 
abilities. Another possible explanation for the 
significant decline in sperm motility of the rats 
that received drug could be as a result of the 
ability of the drugs to pass through the blood-
testis barrier. Raji and co-workers (20) reported 
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that a significant decline in sperm motility 
following the administration of a chemical agent 
could be associated with the ability of the agent to 
permeate the blood-testis barrier and thus, create 
a different microenvironment in the inner aspects 
of the seminiferous tubules when compared with 
its outer parts (20).
Decline in serum testosterone levels 
observed dur ing the  per iod of  drug 
administration suggests a possible deleterious 
effect of administration of VIG, CBZ and or its 
combination on the secretory function of 
testicular androgen. The biosynthesis of 
androgens by the Leydig cells and the production 
of spermatozoa in the epithelium of seminiferous 
tubules are two independent but synchronized 
functions that controls overall testicular function 
(27). Male libido, spermatogenesis as well as 
growth and development of male reproductive 
organs are controlled by androgens (testosterone 
and androsterone), particularly testosterone in 
association with follicle stimulating hormone 
(FSH) (28).
Despite the significant (CBZ only) and 
increase in serum FSH levels and an apparently 
uninterrupted secretion of LH that were recorded 
after 8 weeks drug treatment, there was a 
decrease in the amounts of serum testosterone in 
the experimental groups when compared with the 
control group. This suggests that the decreases in 
serum testosterone that were recorded during the 
period of administration of vigabatrin, 
carbamazepine and their combinations were 
structural in origin. It could have resulted from 
inability of the Leydig cells in the testes to 
respond to available serum LH due to histological 
distortions. This explains the secondary 
manifestations of significant reductions in sperm 
characterization that were recorded in this study 
during the period of drug administration, since 
testosterone is responsible for the sequence of the 
remaining stages of spermatogenesis after 
proliferation of spermatogonia by FSH. While 
FSH is responsible for the initiation of 
spermatogenesis, testosterone is responsible for 
the maintenance of spermatogenesis (28, 29). 
Luteinizing hormone (LH) is, however, essential 
for the secretion of testosterone from Leydig cells 
(30). These reproductive hormones are 
biologically connected such that alteration(s) in 
one factor may elicit deleterious disturbance(s) in 
reproductive functions. Although, the study 
recorded a restoration in the sperm characteristics 
(sperm count,  motil i ty,  viabil i ty and 
morphology) of rats after 8 weeks recovery 
period when compared to the control group, the 
significant decrease in serum testosterone levels 
that was induced was found to be irreversible. 
CONCLUSION
Long-term treatment with VIG, CBZ or its 
combination produced a pathophysiological 
derangement in the hormonal profile of pituitary-
gonadal axis and morphological integrity of the 
testis. This is evident that administration of these 
drug(s) induces a reversible impairment to the 
reproductive hormones and sperm profiles. It is 
possible that the active reversal of sperm 
characteristics that was observed was due to the 
elimination of the drugs from the animals after 
8weeks of administration.  However, these 
factors seemed insufficient to attenuate 
alterations in serum testosterone levels. This is 
subject to further studies.
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Table1: Effects of vigabatrin, carbamazepine or its combination on the body weight of maleWistar rats 
 
Groups Initial body weight (g) Final body weight (g) Percentage weight gain (%) 
Control 170.00 ± 0.15  236.40 ± 0.17  28.09 ± 4.57 
  (272.00 ± 0.21)  (13.09 ± 2.57) 
VIG (200mg/kg) 172.00 ± 0.18  183.80 ± 0.13? 6.42 ± 0.89 á 
  (218.80 ± 0.22 ? ) (16.00 ± 3.60*) 
CBZ (200mg/kg) 168.20 ± 0.16  217.70 ± 0.18 ? 22.74± 3.68 ? 
  (244.70 ± 0.24 ?  ) (11.03 ± 2.48 ? ) 
VIG (100mg/kg) + CBZ (100mg/kg) 175.40 ± 0.20  203.33 ± 0.17 ? 13.73 ±2.39 ? 
  (216.30 ± 0.19 ? ) (6.00 ± 0.77 ? ) 
VIG (200mg/kg) + CBZ (200mg/kg) 168.40 ± 0.02  208.00 ± 0.21 ? 19.04± 1.05 ? 
  (239.00 ± 0.24 ? ) (12.97± 3.05) 
Data are presented as Mean±SEM (n=5); 
ásignificant decrease (p <0.05) compared to the control group.  
*significant increase at p (<0.05) compared to the control group.  




Table 2: The effects of vigabatrin, carbamazepine or its combination on sperm indices in male Wistar rat 
 
Treatment Group Sperm Count 
(106/ml) 
% Motility % 
Morphology 
% Viability 
Control 130.4 ± 0.5 
(132.0 ± 0.5) 
91.6 ± 0.4 
(86.6 ± 0.7) 
15.2 ± 0.7 ? 
(15.0 ± 0.9) 
98.0 ± 0.32 
(95.4 ± 0.2) 
VIG (200mg/kg) 117.6 ± 0.9? 
(118.0 ± 0.8)? 
77.6 ± 0.5? 
(82.2 ± 0.4)? 
11.6 ± 0.4 ? 
(13.2 ± 04) ? 
97.0 ± 0.3 ? 
(93.0 ± 0.3) ? 
CBZ (200mg/kg) 105.0 ± 0.9? 
(102.0 ± 0.4)? 
75.2 ± 0.7? 
(76.6 ± 0.5) ? 
12.0 ± 0.3 ? 
(14.0 ± 0.4) 
97.2 ± 0.5 ? 
( 95.4 ± 0.4) 
VIG (100mg/kg) + CBZ (100mg/kg) 102.8 ± 0.9? 
(102.0 ± 0,4)? 
72.0 ± 1.6 ? 
(85.0 ± 0.3) 
13.4 ± 0.7 ? 
(14.8 ±0.4) 
96 6 ± 0.3 ? 
(95.6 ± 0.5) 
VIG (200mg/kg) + CBZ (200mg/kg) 96.0 ± 15.4? 
(12.6 ± 0.7) 
80.6 ± 0.7? 
(85.6 ± 0.8) 
9.40 ± 0.5 ? 
(14.6 ± 0.32) 
97.0 ± 0.3 ? 
(95.2 ± 0.4) 
Data are presented as Mean±SEM (n=5); 
ásignificant decrease (p <0.05) compared to the control group 
Data are presented as Mean±SEM (n=5); 
ásignificant decrease (p <0.05) compared to the control group.  
*significant increase at p (<0.05) compared to the control group.  
 
Figure 1: Effects of vigabatrin, carbamazepine or its combination on relative epididymal  
weight of treated Wistar rats 
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Data are presented as Mean ± SEM (n=5); 
ásignificant decrease (p <0.05) compared to the control group.  
*significant increase at p (<0.05) compared to the control group.  
 
Figure 2:  Effects of vigabatrin, carbamazepine or its combination on relative  
testicular weight of Wistar rats. 
Data are presented as Mean ± SEM (n=5) 
á significant decrease (p <0.05) compared to the control. 
 
Figure 3: Effects of vigabatrin, carbamazepine or its combination on serum  
testosterone concentration in male Wistar rats 
Data are presented as Mean ± SEM (n=5) 
?Significant decrease at (p<0.05) compared to the control 
 
Figure 4: Effects of vigabatrin, carbamazepine or its combination on serum     
luteinizing hormone concentration in male Wistar rats. 
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Data are presented as Mean±SEM (n=5); 
ásignificant decrease (p <0.05) compared to the control group.  
*significant increase at p (<0.05) compared to the control group.  
 
Figure 5: Effects of vigabatrin, carbamazepine or its combination on serum follicle  
stimulating hormone concentration in male Wistar rats 
 
 
Control        VIG (200mg/kg)       CBZ (200mg/kg) 
 
 
VIG (100mg/kg)+CBZ (100mg/kg)       VIG (200mg/kg)+CBZ (200mg/kg) 
 
Figure 7a: Histomorphology of the testes after 8 weeks administration of VIG, CBZ and VIG-CBZ combination  
 
Control          VIG (200mg/kg)    CBZ (200mg/kg) 
 
 
VIG (100mg/kg)+CBZ (100mg/kg)              VIG (200mg/kg)+CBZ (200mg/kg) 
 
Figure 7b: Histomorphology of the testes after 8 weeks of VIG, CBZ and VIG-CBZ combination drug withdrawal 
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